Zhu Chen Selected Research

fibrin fragment D (D-dimer)

11/2020	A novel risk score to predict diagnosis with coronavirus disease 2019 (COVID-19) in suspected patients: A retrospective, multicenter, and observational study.
8/2012	Quantification of circulating D-dimer by peptide immunoaffinity enrichment and tandem mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhu Chen Research Topics

Disease

57	Neoplasms (Cancer) 12/2023 - 09/2002
44	Acute Promyelocytic Leukemia 02/2024 - 06/2000
40	Leukemia 01/2022 - 02/2002
17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 05/2005
14	COVID-19 01/2024 - 01/2020
12	Inflammation (Inflammations) 02/2024 - 05/2015
12	Infections 01/2024 - 09/2003
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2012 - 12/2004
9	Hematologic Neoplasms (Hematological Malignancy) 12/2021 - 05/2005
7	Thrombosis (Thrombus) 01/2017 - 01/2013
7	Lymphoma (Lymphomas) 10/2013 - 04/2003
6	Hypoxia (Hypoxemia) 01/2024 - 01/2006
6	Atherosclerosis 11/2023 - 06/2010
6	Rheumatoid Arthritis 07/2022 - 03/2013
6	Hemorrhage 12/2021 - 09/2014
5	Multiple Myeloma 04/2024 - 02/2012
5	Obesity 03/2024 - 01/2016
5	Arthritis (Polyarthritis) 02/2024 - 11/2016
5	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 05/2016
5	Genetic Translocation (Chromosomal Translocation) 01/2022 - 11/2002
4	Periodontitis 05/2024 - 01/2022
3	Fibrosis (Cirrhosis) 03/2024 - 05/2017
3	Body Weight (Weight, Body) 12/2023 - 04/2007
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2023 - 04/2012
3	Type 2 Diabetes Mellitus (MODY) 10/2023 - 09/2003
3	Communicable Diseases (Infectious Diseases) 08/2022 - 12/2020
3	Disease Progression 11/2020 - 01/2005
3	Carcinogenesis 10/2020 - 02/2009
3	Weight Gain 02/2019 - 02/2014
3	Graves Disease (Basedow Disease) 10/2018 - 08/2011
3	Carcinoma (Carcinomatosis) 01/2018 - 03/2009
3	Premature Birth (Birth, Premature) 10/2016 - 02/2014
3	Dyslipidemias (Dyslipidemia) 09/2012 - 06/2011
2	Pathologic Processes 03/2024 - 01/2020
2	Cerebral Infarction 03/2024 - 06/2023
2	Lupus Nephritis 11/2023 - 09/2012
2	Sepsis (Septicemia) 10/2023 - 01/2021
2	Stroke (Strokes) 06/2023 - 09/2022
2	Pulmonary Hypertension 01/2023 - 10/2018
2	Chronic Hepatitis B 01/2023 - 07/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 12/2021

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2004
27	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2023 - 02/2002
19	Arsenic Trioxide (Trisenox)FDA Link 12/2023 - 02/2002
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2007
11	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 12/2004
11	ArsenicIBA 01/2018 - 01/2005
9	Imatinib Mesylate (Gleevec)FDA Link 02/2012 - 12/2004
8	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 03/2014
8	AntigensIBA 12/2023 - 01/2006
8	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2007
8	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 02/2010 - 06/2000
7	CytokinesIBA 01/2024 - 02/2014
7	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2018
7	EnzymesIBA 09/2021 - 04/2013
7	Therapeutic UsesIBA 12/2020 - 05/2005
6	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 03/2011
6	Aligeron (AS 2)IBA 02/2005 - 11/2002
5	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2019
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 09/2003
5	Messenger RNA (mRNA)IBA 07/2023 - 09/2008
5	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021 - 10/2007
5	MethyltransferasesIBA 01/2020 - 02/2010
5	Lysine (L-Lysine)FDA Link 01/2020 - 02/2010
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 01/2005
5	Tyrosine Kinase InhibitorsIBA 02/2012 - 02/2006
5	Retinoic Acid Receptor alphaIBA 02/2010 - 02/2002
4	Nucleic AcidsIBA 08/2022 - 01/2020
4	CholesterolIBA 01/2021 - 06/2010
4	Phosphotransferases (Kinase)IBA 01/2018 - 05/2005
4	Small Interfering RNA (siRNA)IBA 06/2015 - 09/2008
4	Arsenicals (Arsenic Compounds)IBA 04/2012 - 09/2002
3	B-Cell Maturation AntigenIBA 04/2024 - 01/2019
3	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
3	Insulin (Novolin)FDA Link 12/2023 - 02/2014
3	oxidized low density lipoproteinIBA 11/2023 - 06/2011
3	C-Reactive ProteinIBA 01/2023 - 11/2020
3	Competitive Endogenous RNAIBA 01/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2011
3	Long Noncoding RNAIBA 05/2021 - 01/2018
3	AcidsIBA 05/2021 - 02/2012
3	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2020
3	Histones (Histone)IBA 01/2020 - 02/2010
3	Histone Deacetylase InhibitorsIBA 01/2019 - 12/2007
3	GlucosidesIBA 10/2016 - 03/2013
3	ApolipoproteinsIBA 01/2012 - 06/2011
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2012 - 12/2010
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2008 - 01/2007
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 12/2023
2	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2024 - 05/2022
2	LipidsIBA 12/2023 - 11/2016
2	Circular RNAIBA 11/2023 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	InterferonsIBA 01/2023 - 01/2011

Therapy/Procedure

44	Therapeutics 02/2024 - 05/2002
9	Drug Therapy (Chemotherapy) 12/2021 - 04/2003
3	Immunotherapy 12/2023 - 11/2020
3	Anesthesia 04/2019 - 06/2018
2	Aftercare (After-Treatment) 04/2024 - 11/2023
2	Photothermal Therapy 01/2023 - 02/2021